FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025778844> ?p ?o ?g. }

• W3025778844 endingPage "153" @default.
• W3025778844 startingPage "149" @default.
• W3025778844 abstract "Retinoblastoma (RB) is a malignant tumor presenting in the eyes of infants and children, which endangers life, the eye and vision. The treatment of RB has undergone marked changes in recent years, and great progress has been made in our ability to preserve eyes. Over the last three decades most Israeli patients with RB have been treated in the National Specialty Ocular Oncology Service at the Hadassah-Hebrew University Medical Center in Jerusalem.To describe advances in the primary treatment of RB with an emphasis on eye-preserving treatments.The study included a retrospective cohort of patients who were diagnosed and treated at our center over the last three decades. Review of patients' records was approved by the Hadassah IRB.From 1988 to 2014 we diagnosed 290 children (138 girls - 47.6%). The mean age at diagnosis (±SE) was 18.1±1.2 months, median 12.5 months. RB was unilateral in 55.6% of the cases, bilateral in 41.3% and unilateral multifocal in 3.1%. There was an even distribution of disease severity (IRB grouping). Since the advent of IV chemotherapy (IVC) there has been a decrease in the rate of eye enucleation from ~90% to ~30% of the children until the year 2000 with a stable rate thereafter. In the years 1990-2000 there was an increase followed by a decrease in the use of primary external beam radiotherapy (EBRT), and a parallel small increase in the use of brachytherapy from the mid '90s until today. The recently introduced novel treatments - intravitreal (IVitC) and intra-arterial chemotherapy (IAC) - were used as a complimentary treatment to IVC, and not yet as a single primary modality until 2014.IVC replaced the need to enucleate in most of the cases, but 30% of children still require a primary enucleation.IVC usually requires additive treatments (thermal-cryotherapy, trans-pupillary thermotherapy - TTT, brachytherapy and/or local chemotherapy - IVitC and IAC) and with the use of multi-modal therapy many eyes can be preserved. In the period reported in the current manuscript, the use of IAC as a primary treatment approach was only used in isolated cases. In Summary, There have been significant advances in our ability to save eyes, and the field continues to progress." @default.
• W3025778844 created "2020-05-21" @default.
• W3025778844 creator A5023982171 @default.
• W3025778844 creator A5034958638 @default.
• W3025778844 creator A5070805596 @default.
• W3025778844 creator A5079544875 @default.
• W3025778844 creator A5081265839 @default.
• W3025778844 date "2018-03-01" @default.
• W3025778844 modified "2023-09-26" @default.
• W3025778844 title "[ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES]." @default.
• W3025778844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29582943" @default.
• W3025778844 hasPublicationYear "2018" @default.
• W3025778844 type Work @default.
• W3025778844 sameAs 3025778844 @default.
• W3025778844 citedByCount "1" @default.
• W3025778844 countsByYear W30257788442022 @default.
• W3025778844 crossrefType "journal-article" @default.
• W3025778844 hasAuthorship W3025778844A5023982171 @default.
• W3025778844 hasAuthorship W3025778844A5034958638 @default.
• W3025778844 hasAuthorship W3025778844A5070805596 @default.
• W3025778844 hasAuthorship W3025778844A5079544875 @default.
• W3025778844 hasAuthorship W3025778844A5081265839 @default.
• W3025778844 hasConcept C104317684 @default.
• W3025778844 hasConcept C126322002 @default.
• W3025778844 hasConcept C141071460 @default.
• W3025778844 hasConcept C167135981 @default.
• W3025778844 hasConcept C185592680 @default.
• W3025778844 hasConcept C187212893 @default.
• W3025778844 hasConcept C188261085 @default.
• W3025778844 hasConcept C20387591 @default.
• W3025778844 hasConcept C2776577112 @default.
• W3025778844 hasConcept C2777416452 @default.
• W3025778844 hasConcept C2994186761 @default.
• W3025778844 hasConcept C509974204 @default.
• W3025778844 hasConcept C512399662 @default.
• W3025778844 hasConcept C55493867 @default.
• W3025778844 hasConcept C71924100 @default.
• W3025778844 hasConcept C72563966 @default.
• W3025778844 hasConceptScore W3025778844C104317684 @default.
• W3025778844 hasConceptScore W3025778844C126322002 @default.
• W3025778844 hasConceptScore W3025778844C141071460 @default.
• W3025778844 hasConceptScore W3025778844C167135981 @default.
• W3025778844 hasConceptScore W3025778844C185592680 @default.
• W3025778844 hasConceptScore W3025778844C187212893 @default.
• W3025778844 hasConceptScore W3025778844C188261085 @default.
• W3025778844 hasConceptScore W3025778844C20387591 @default.
• W3025778844 hasConceptScore W3025778844C2776577112 @default.
• W3025778844 hasConceptScore W3025778844C2777416452 @default.
• W3025778844 hasConceptScore W3025778844C2994186761 @default.
• W3025778844 hasConceptScore W3025778844C509974204 @default.
• W3025778844 hasConceptScore W3025778844C512399662 @default.
• W3025778844 hasConceptScore W3025778844C55493867 @default.
• W3025778844 hasConceptScore W3025778844C71924100 @default.
• W3025778844 hasConceptScore W3025778844C72563966 @default.
• W3025778844 hasIssue "3" @default.
• W3025778844 hasLocation W30257788441 @default.
• W3025778844 hasOpenAccess W3025778844 @default.
• W3025778844 hasPrimaryLocation W30257788441 @default.
• W3025778844 hasRelatedWork W1570762886 @default.
• W3025778844 hasRelatedWork W1978738846 @default.
• W3025778844 hasRelatedWork W2065129394 @default.
• W3025778844 hasRelatedWork W2330375955 @default.
• W3025778844 hasRelatedWork W2501869058 @default.
• W3025778844 hasRelatedWork W2592456729 @default.
• W3025778844 hasRelatedWork W2977994339 @default.
• W3025778844 hasRelatedWork W3009342005 @default.
• W3025778844 hasRelatedWork W3021484975 @default.
• W3025778844 hasRelatedWork W4200477509 @default.
• W3025778844 hasVolume "157" @default.
• W3025778844 isParatext "false" @default.
• W3025778844 isRetracted "false" @default.
• W3025778844 magId "3025778844" @default.
• W3025778844 workType "article" @default.